Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.5401
Delayed Data
As of Jul 29
 +0.0094 / +1.77%
Today’s Change
0.47
Today|||52-Week Range
2.50
-59.39%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Navidea Biopharmaceuticals Inc have a median target of 2.40, with a high estimate of 2.40 and a low estimate of 2.40. The median estimate represents a +344.36% increase from the last price of 0.54.

Analyst Recommendations

There are no recommendations available.

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.02
Sales
$5.5M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually 55.56%
 
 
 
 
 
 

Sales

Growthquarterly 16.46%
 
 
 
 
 
 
Growthannually 78.12%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.